deferasirox has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avril, S; Garcion, E; Guillet, C; Legendre, C | 1 |
1 other study(ies) available for deferasirox and Glioblastoma
| Article | Year |
|---|---|
Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.
Topics: Benzoates; Cell Hypoxia; Cell Line, Tumor; Combined Modality Therapy; Deferasirox; Drug Resistance, Neoplasm; Glioblastoma; Humans; Iron Chelating Agents; Oxygen; Triazoles | 2016 |